Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight
14 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight The demand for organoids is being driven mainly by an...
Organoids Market worth $12.20 Billion by 2030 - Exclusive Report by The Insight Partners
01 sept. 2023 10h08 HE
|
The Insight Partners
Pune, India, Sept. 01, 2023 (GLOBE NEWSWIRE) -- An organoid is a miniaturized and simplified version of an organ fabricated in vitro in three dimensions that mimics the essential functional,...
Organoids Market (Source, Type) - Reach $8.12 Billion by 2028 at 21.8% CAGR with Intestine Segment Driving Growth During 2023–2028 | The Insight Partners
01 juin 2023 09h59 HE
|
The Insight Partners
Pune, India., June 01, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Organoids Market Size Report, Share, Revenue, Growth Strategy, Industry Trends and Forecast...
3D Cell Culture Market to hit USD 5.5 billion by 2032, says Global Market Insights Inc.
17 mai 2023 06h00 HE
|
Global Market Insights Inc.
Selbyville, Delaware, May 17, 2023 (GLOBE NEWSWIRE) -- 3D Cell Culture Market size is estimated to reach USD 5.5 billion by 2032, according to a new research report by Global Market Insights...
Rumi Scientific Announces Data Demonstrating Disease Modifying Effect of BRD9 Inhibition in a Huntington’s Disease Animal Model
26 avr. 2023 07h05 HE
|
Rumi Scientific, Inc.
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...
Rumi Scientific Appoints Allen A. Fienberg, Ph.D., as Chief Executive Officer and Chairman of the Board of Directors
30 mars 2023 08h00 HE
|
Rumi Scientific, Inc.
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...
BioMed X and AbbVie Extend Research Collaboration in the US
16 janv. 2023 13h00 HE
|
BioMed X Institute
HEIDELBERG, Germany, Jan. 16, 2023 (GLOBE NEWSWIRE) -- BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie....
Organoids and Spheroids Market Is Expected to Reach $1.2 Billion by 2031: Allied Market Research
24 août 2022 12h00 HE
|
Allied Market Research
Portland, OR, Aug. 24, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global organoids and spheroids market generated $516.6 million in 2021, and is...
Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease
29 mars 2022 17h00 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J. and Esch-sur-Alzette, Luxembourg, March 29, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug...
Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
16 août 2021 16h01 HE
|
Vyant Bio, Inc.
Strategic Highlights Received an issued US Patent titled “High Throughput Optical Assay of Human Mixed Cell Population Spheroids” by the United States...